Evidence map›Paper›PMID 42004355›Full record

ReviewACS omega2026

Iron-Catalyzed Nucleophilic Substitution Reactions: An Overview.

Sasidharan Ramamoorthy, Mridula Ramasubramanian, Niharan Sivaraj, Toshifumi Dohi, Fateh V Singh

Abstract readReview
In one paragraph

Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sasidharan RamamoorthyChemistry Department, SAS, Vellore Institute of Technology - Chennai Campus, Vandalur-Kelambakkam Road, Chennai, Tamil Nadu 600127, India.
Mridula RamasubramanianChemistry Department, SAS, Vellore Institute of Technology - Chennai Campus, Vandalur-Kelambakkam Road, Chennai, Tamil Nadu 600127, India.
Niharan SivarajChemistry Department, SAS, Vellore Institute of Technology - Chennai Campus, Vandalur-Kelambakkam Road, Chennai, Tamil Nadu 600127, India.
Toshifumi DohiCollege of Pharmaceuticals Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga 525-0058, Japan.ORCID https://orcid.org/0000-0002-2812-9581
Fateh V SinghChemistry Department, SAS, Vellore Institute of Technology - Chennai Campus, Vandalur-Kelambakkam Road, Chennai, Tamil Nadu 600127, India.ORCID https://orcid.org/0000-0002-6358-4408

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transition metal complexes have become increasingly important as catalysts in organic synthesis. Iron has emerged as an exceptionally versatile, cost-effective, and sustainable catalyst in contemporary organic synthesis owing to its competitive reactivity and selectivity. It efficiently overcomes the limitations of noble metal catalysts and substitutes for precious transition metals. Selective reduction of olefins, alkynes, and carboxylic derivatives as well as cross-coupling reactions involving C-O cleavage have been facilitated the use of iron as a catalyst, enhancing the catalyst scope in addition to the asymmetric synthesis employing chiral iron catalysts.Currently, heterogeneous iron catalysts showcase superior performance and have vast applications in industries, notably as iron-oxide-hybridized support systems such as clay, aluminosilicates, metal oxides, or polymeric matrices, which carbonize metals to perform various catalytic reactions. Among numerous applications, iron-catalyzed nucleophilic substitution processes are particularly significant, as they provide convenient access to C-C, C-N, C-O, and C-S bond formation in an efficient manner under mild and operationally friendly conditions. This review outlines the progress in iron-catalyzed nucleophilic substitutions with a focus on mechanistic insights, substrates involving benzylic, allylic, and propargylic, and the compatibility of functional groups such as alcohols, amine, amide, ketone, keto acids, etc., in supporting synthetic utility.

Identifiers

PMID42004355
PMCPMC13084439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.